Ibract® Capsule

(Palbociclib 75 mg ,100mg &125 mg)

GENERIC NAME: Palbociclib 75 mg ,100mg &125 mg

THERAPEUTIC CLASS: Kinase Inhibitor / Antineoplastic Agent

INDICATIONS & DOSAGE: It is used to treat patients with certain types of breast cancer (hormone receptor-positive, human epidermal growth factor receptor 2-negative) which have spread beyond the original tumor and/or to other organs.

STORAGE: Store below 30° C. Protected from light and moisture.

PACK SIZE: 3X7’s

DOSAGE & ADMINISTRATION:

The recommended dose is 125 mg taken once a day for 3 weeks followed by one week without taking Ibract.